Effect of Heat on Rivastigmine TDS Products

Clinical trial NCT03915626 · COMPLETED

Trial details

NCT number: NCT03915626
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Bioavailability

Start date: 2019-10-04
Primary completion: 2021-05-04
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.